| HRCIX | VIGRX | HRCIX / VIGRX | |
| Total Expense Ratio | 0.75 | 0.17 | 441% |
| Annual Report Gross Expense Ratio | 0.75 | 0.17 | 441% |
| Fund Existence | 20 years | 33 years | - |
| Gain YTD | 20.050 | 16.773 | 120% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 3000 | 333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 570M | 357B | 0% |
| Annual Yield % from dividends | 0.00 | 0.30 | 1% |
| Returns for 1 year | 9.50 | 19.95 | 48% |
| Returns for 3 years | 42.87 | 111.80 | 38% |
| Returns for 5 years | 22.10 | 100.53 | 22% |
| Returns for 10 years | 73.16 | 337.53 | 22% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 31.90 | 0.36 | +1.14% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| SDSI | 51.59 | 0.05 | +0.10% |
| American Century® Short Dur Str Inc ETF | |||
| IBMQ | 25.52 | 0.01 | +0.06% |
| iShares iBonds Dec 2028 Term Muni Bd ETF | |||
| THIR | 31.18 | -0.25 | -0.78% |
| THOR Index Rotation ETF | |||
| FBCG | 52.25 | -0.73 | -1.38% |
| Fidelity Blue Chip Growth ETF | |||